| Heart transplant with myoclonus N: 147 | Heart transplant without myoclonus N: 56,271 | P value |
Age (mean ± SD) | 64.8 ± 10.3 | 55.4 ± 20.4 | 0.01 |
Age ≥65 yrs | 83 (56.8%) | 23,644 (42.0%) | 0.12 |
Female | 34 (23.2%) | 16,130 (28.3%) | 0.48 |
Medical Comorbidities |
|
|
|
Diabetes Mellitus | 89 (60.6%) | 23,625 (41.2) | 0.04 |
Congestive Heart Failure | 24 (16.0%) | 6552 (11.6%) | 0.47 |
Hypertension | 94 (63.7%) | 35,523 (63.1%) | 0.94 |
Hyperlipidemia | 83 (56.9%) | 23,394 (41.6%) | 0.11 |
Atrial Fibrillation | 9 (6.5%) | 4883 (8.67%) | 0.63 |
Renal Failure | 94 (64.0%) | 27,520 (48.9%) | 0.08 |
Hypercoagulable state | 0 | 3905 (6.93%) | - |
Chronic Lung Disease | 19 (13.0%) | 8225 (14.6%) | 0.78 |
In-hospital complications |
|
|
|
Acute Kidney Injury | 98 (66.8%) | 20,843 (37.0%) | 0.01 |
Pneumonia | 19 (13.2%) | 5776 (10.3%) | 0.63 |
Urinary Tract Infection | 4.5 (3.11%) | 4939 (8.77%) | 0.09 |
Sepsis | 29 (19.8%) | 4145 (7.36%) | 0.15 |
Outcomes |
|
|
|
Prolonged length of stay | 83 (56.5%) | 14,647 (26.0%) | 0.002 |
Discharge disposition of alive patients to nursing home | 39 (30.7%) | 6267 (11.4%) | 0.05 |
In-hospital mortality | 19 (13.5%) | 1167 (2.07%) | 0.08 |